Alpha-melanocyte stimulating hormone promotes regrowth of injured axons in the adult rat spinal cord

Journal of Neurotrauma

Volumn 16, Issue 6, 1999, Pages 543-553

  Joosten, Elbert A J ^b   Majewska, Barbara ^a   Houweling, Diane A ^c   Bär, Peter R ^c   Gispen, Willem Hendrik ^c  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b UTRECHT UNIVERSITY   (Netherlands)

^c NONE

Author keywords

Alpha melanocyte stimulating hormone; Rat; Regeneration; Spinal cord injury

Indexed keywords

ALPHA INTERMEDIN; COLLAGEN; CORTICOTROPIN; INTERMEDIN; MELANOCORTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IMAGE ANALYSIS; LAMINECTOMY; MALE; NERVE GROWTH; NERVE LESION; NERVE REGENERATION; NEURITE; NONHUMAN; PERIPHERAL NERVE INJURY; RAT; SPINAL CORD INJURY;

EID: 0033039884     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1999.16.543     Document Type: Article

References (36)

1. ADAN, R.A.H., VAN DER KRAAN, M., DOORNBOS, R.P., BAR, P.R., BURBACH, J.P.H., and GISPEN, W.H. (1996). Melanocortin receptors mediate α-MSH induced stimulation of neurite outgrowth in Neuro 2A cells. Mol. Brain Res. 36, 37-44.
2. EDWARDS, P.M., VAN DER ZEE, C.E.E.M., VERHAAGEN, J., SCHOTMAN, P., JENNEKENS, F.G.I., and GISPEN, W.H. (1984). Evidence that the neurotrophic action of α-MSH may derive from its inability to mimic the actions formed in degenerating nerve stumps. J. Neurol. Sci. 64, 333-340.
3. GISPEN, W.H., VERHAAGEN, J., and BARR, P.R. (1994). ACTH/MSH-derived peptides and peripheral nerve plasticity: neuropathies, neuroprotection and repair. Prog. Brain Res. 100, 223-233.
4. HEFFNER, C.D., LUMSDEN, A.G.S., and O'LEARY, D.D.M. (1990). Target control of collateral extension and directional growth in the mammalian brain. Science 247, 1079-1080.
5. HOL, E.M., GISPEN, W.H., and BAR, P.R. (1995). ACTH-related peptides: receptor and signal transduction systems involved in their neurotrophic and neuroprotective actions. Peptides 16, 979-993.
6. HOUWELING, D.A., BAR, P.R., GISPEN, W.H., and JOOSTEN, E.A.J. (1998). Spinal cord injury: bridging the lesion and the role of neurotrophic factors in repair. Prog. Brain Res. 117, 455-471.
7. HOUWELING, D.A., LANKHORST, A.J., GISPEN, W.H., BAR, P.R., and JOOSTEN, E.A.J. (1998). Collagen-containing neurotrophin-3 (NT-3) attracts regrowing injured corticospinal axons in the adult rat spinal cord and promotes partial functional recovery. Exp. Neurol. 153, 49-59.
8. JOOSTEN, E.A.J. (1997). Corticospinal tract regrowth. Prog. Neurobiol. 35, 1-25.
9. JOOSTEN, E.A.J., BAR, P.R., and GISPEN, W.H. (1995a). Collagen implants and corticospinal regrowth after mid-thoracic spinal cord lesion in the adult rat. J. Neurosci. Res. 41, 481-490.
10. JOOSTEN, E.A.J., BAR, P.R., GISPEN, W.H., and BREGMAN, B.S. (1993). Transient projections from rat occipital cortex are able to respond to a spinal target derived diffusible factor in vitro. Neurosci. Lett. 164, 85-88.
11. JOOSTEN, E.A.J., GISPEN, W.H., and BAR, P.R. (1994). Tropism and corticospinal target selection in the rat. Neuroscience 59, 33-41.
12. JOOSTEN, E.A.J., GISPEN, W.H., and BAR, P.R. (1995b). Directional regrowth of lesioned corticospinal tract axons in adult rat spinal cord. Neuroscience 69, 619-626.
13. JOOSTEN, E.A.J., VAN DE MEENT, H., BAR, P.R., and GISPEN, W.H. (1995c). Melanocortins stimulate neurite outgrowth in the injured rat spinal cord. J. Neurotrauma 12, 373(abst).
14. JOOSTEN, E.A.J., VAN DER VEN, P.F.M., HOOIVELD, M.H.W., and TEN DONKELAAR, H.J. (1991). Induction of corticospinal target finding by release of a diffusible, chemotropic factor in cervical spinal gray matter. Neurosci. Lett. 128, 25-28.
15. JOOSTEN, E.A.J., VERHAAGH, S., MARTIN, D., et al. (1996). Alpha-MSH stimulates neupite outgrowth of neonatal rat corticospinal neurons in vitro. Brain Res. 736, 90-98.
16. KOKA, P., HE, K., CAMERINI, D., TRAN, T., YASHAR, S.S., and MERRILL, J.E. (1995). The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor production in glial cells. J. Neuroimmunol. 57, 179-191.
17. LUMSDEN, A.G.S., and DAVIES, A.M. (1983). Earliest sensory nerve fibers are guided to peripheral targets by attractants other than nerve growth factor. Nature 306, 786-788.
18. MARCHAND, R., and WOERLY, S. (1990). Transected spinal cords grafted with in situ self-assembled collagen matrices. Neuroscience 36, 45-60.
19. NYAKAS, C., VELDHUIS, H.D., and DE WIED, D. (1985). Beneficial effect of chronic treatment with ORG 2766 and αMSH on impaired reversal learning of rats with bilateral lesions of the parafascicular area. Brain Res. Bull. 15, 257-265.
20. OESTREICHER, A.B., ZWIERS, H., GISPEN, W.H., and ROBERTS, S. (1982). Characterization of infant rat cerebral cortical membrane proteins phosphorylated in vivo: identification of the ACTH-sensitive phosphoprotein B-50. J. Neurochem. 39, 683-692.
21. PAINO, C.L., FERNANDEZ-VALLE, C., BATES, M.L., and BUNGE, M.B. (1994). Regrowth of axons in lesioned adult rat spinal cord: promotion by implants of cultured schwann cells. J. Neurocytol. 23, 433-452.
22. PITSIKAS, N., SPRUIJT, B.M., JOSEPHY, M., ALGERI, S., and GISPEN, W.H. (1991). Effect of ORG 2766, an ACTH (4-9) analogue, on recovery after bilateral transection of fimbria fornix in the rat. Pharmacol. Biochem. Behav. 38, 931-934.
23. ROSELLI-REHFUSS L., MOUNTYOJ, K.G., ROBBINS, L.S., et al. (1993). Identification of a receptor for α melanotrophin and other pro-opiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. U.S.A. 90, 8856-8860.
24. RAJORA, N., BOUOLI, G., BURNS, D., SHARMA, S., CATANIA, A.P., and LYSTON, J.M. (1997). α-MSH modulates local and circulating tumor necrosis factro-α in experimental brain inflammation. J. Neurosci. 17, 2181-2186.
25. SCHNELL, L., and SCHWAB, M.E. (1990). Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 343, 269-272.
26. SCHNELL, L., SCHNEIDER, R., KOLBECK, R., BARDE, Y.A., and SCHWAB, M.E. (1994). Neurotrophin-3 enhances sprouting of corticospinal tract during development and after spinal cord lesions. Nature 367, 170-173.
27. SCHWAB, M.E., and BARTHOLDI, D. (1996). Degeneration and regeneration in the lesioned spinal cord. Physiol. Rev. 76, 319-370.
28. STRAND, F.L., ROSE, K.J., KING, J.A., SEGARRA, A.C., and ZUCHARELLI, L.A. (1989). ACTH-modulation of nerve development and regeneration. Prog. Neurobiol. 33, 45-85.
29. TASCOS, N.A., PARR, J., and GONATAS, N.K. (1982). Immunocytochemical study of the glial fibrillary acidic protein in human neoplasms of the central nervous system. Hum. Pathol. 13, 454-458.
30. VAN DE MEENT, H., JOOSTEN, E.A.J., and GISPEN, W.H. (1995). Beneficial effects of melanocortins on spinal function after spinal cord injury in the rat. J. Neurotrauma 12, 466(abst).
31. VAN DE MEENT, H., HAMERS, F.P.T., JOOSTEN, E.A.J., and GISPEN, W.H. (1996). Beneficial effects of the melanocortin α-MSH on clinical and neurophysiological recovery after experimental spinal cord injury. Neurosurgery 40, 1-10.
32. VAN DER NEUT, R., BAR, P.R., SODAAR, P., and GISPEN, W.H. (1988). Trophic influences of alpha-MSH and ACTH4-10 on neuronal outgrowth in vitro. Peptides 9, 1015-1020.
33. VAN DER NEUT, R., HOL, E.M., GISPEN, W.H., and BAR, P.R. (1992). Stimulation by melanocortins of neurite outgrowth from spinal and sensory neurons in vitro. Peptides 13, 1109-1115.
34. VERHAAGEN, J., EDWARDS, P.M., JENNEKENS, F.G.I., SCHOTMAN, P., and GISPEN, W.H. (1986). α-Melanocyte stimulating hormone stimulates the outgrowth of myelinated fibers after peripheral nerve crush. Exp. Neurol. 92, 451-454.
35. WOLTERINK, G., and VAN REE, J.M. (1990). Functional recovery after destruction of dopamine systems in the nucleus accumbens of rats III Further analysis of the facilitating effect of the ACTH (4-9) analog ORG 2766. Brain Res. 507, 109-114.
36. WOLTERINK, G., VAN ZANTEN, E., and VAN REE, J.M. (1990). Functional recovery after destruction of dopamine systems in the nucleus accumbens of rats. IV. Delay by intra-accumbal treatment with ORG 2766-or alpha-MSH antiserum. Brain Res. 507, 115-120.